Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in

B Bouzahzah1, M Fu, A Iavarone

  • 1The Albert Einstein Cancer Center, Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Cancer Research
|September 2, 2000
PubMed

Insights

Transforming growth factor-beta1 (TGF-β1) suppresses tumors by reducing cdc25A protein. This involves increased binding of histone deacetylase 1 (HDAC1) to p130, inhibiting cdc25A gene expression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Transforming growth factor-beta1 (TGF-β1) is recognized for its tumor suppressor functions.
  • Cyclin-dependent kinase (CDK) regulators play critical roles in cell cycle control and cancer development.
  • Histone deacetylases (HDACs) and pocket proteins are involved in gene regulation and cellular processes.

Purpose of the Study:

  • To investigate the mechanism by which TGF-β1 inhibits cdc25A protein abundance in vivo.
  • To explore the role of histone deacetylase 1 (HDAC1) and p130 in TGF-β1-mediated regulation of cdc25A.
  • To elucidate the link between chromatin remodeling, CDK inhibition, and TGF-β1 signaling in hepatic cells.

Main Methods:

  • Utilized transgenic mice with hepatic TGF-β1 overexpression.
  • Performed chromatin immunoprecipitation (ChIP) assays to assess protein binding to DNA.
  • Analyzed protein levels, promoter activity, and DNA synthesis in cultured cells and liver tissues.

Main Results:

  • Hepatic TGF-β1 overexpression led to reduced cdc25A protein levels.
  • Reduced cdc25A was associated with increased binding of HDAC1 to p130.
  • HDAC1/p130 overexpression inhibited cdc25A promoter activity via an E2F site; TGF-β1 enhanced this binding.
  • Hepatic proliferation decreased HDAC1 binding to p130, while cdc25A induction correlated with DNA synthesis.

Conclusions:

  • TGF-β1 may inhibit cdc25A gene expression by enhancing HDAC1 binding to p130 in vivo.
  • TGF-β1's regulation of HDAC1/pocket protein associations provides a link between chromatin remodeling and CDK inhibition.
  • This mechanism highlights a novel pathway for TGF-β1's tumor suppressor activity involving cdc25A regulation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...